The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Chronic Reductions in Serotonin Transporter Function Prevent 5-HT1B-Induced Behavioral Effects in Mice
Open accessAbstract
Background Obsessive-compulsive disorder (OCD) is characterized by intrusive thoughts, images, or impulses and/or repetitive stereotypical behavior. Obsessive-compulsive disorder patients exhibit reduced prepulse inhibition (PPI) and symptom exacerbation after challenge with 5-HT1B receptor agonists. Recently, gain-of-function alleles of the serotonin transporter (5-HTT) have been associated with OCD. We tested the hypothesis that reducing 5-HTT function chronically, either genetically or via serotonin reuptake inhibitor (SRI) treatment, attenuates PPI deficits and perseverative hyperlocomotion induced by 5-HT1B agonists in mice.Methods Mice received subchronic or chronic pretreatment with the SRI fluoxetine and acute treatment with RU24969 (5-HT1A/1B agonist) or 8-OH-DPAT (5-HT1A agonist) and were assessed for PPI, locomotor activity, and spatial patterns of locomotion. The same measures were evaluated in 5-HTT wild-type (WT), heterozygous (HT), and knockout (KO) mice after RU24969 treatment. The effects of WAY100635 (5-HTA antagonist) or GR127935 (5-HT1B/D antagonist) pretreatment on RU24969-induced effects were evaluated. Finally, 5-HT1B binding and functional coupling were assessed in 5-HTT-WT, -HT, and -KO mice, and normal fluoxetine-treated mice.Results Chronic, but not subchronic, fluoxetine treatment prevented RU24969-induced PPI deficits and perseverative hyperlocomotion. These RU24969-induced effects were mediated via 5-HT1B and not 5-HT1A receptors. 5-HTT-KO mice showed no effects of RU24969, and 5-HTT-HT mice exhibited intermediate phenotypes. 5-HT1B binding and functional coupling were reduced in the globus pallidus and substantia nigra of 5-HTT-KO mice.Conclusions Our results demonstrate that chronic, but not subchronic, fluoxetine treatment and 5-HTT knockout robustly attenuate 5-HT1B agonist-induced PPI deficits and perseverative hyperlocomotion. These results may have implications for the etiology and treatment of OCD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies in mice demonstrate that administration of a 5-HT1B agonist leads to OCD-relevant perseverative locomotion and prepulse inhibition deficits, both of which are reversed with chronic, but not acute, fluoxetine treatment 38.”
From DISSECTING OCD CIRCUITS: FROM ANIMAL MODELS TO TARGETED TREATMENTS: Review: Dissecting OCD Circuits: Animals to Treatments (2015) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BRAFF, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,701
Self-citationGeyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
Self-citationHu, X.-Z., Lipsky, R., Zhu, G., Akhtar, L. A., Taubman, J., Greenberg, B., Xu, K., Arnold, P., Richter, M., Kennedy, J., et al. (2006) · American Journal of Human Genetics · doi:10.1086/503850 · Cited by 1,215
The more or less startling effects of weak prestimulation
Graham, F. K. (1975) · Psychophysiology · doi:10.1111/j.1469-8986.1975.tb01284.x · Cited by 1,119
Neuropsychopharmacology: The Fifth Generation of Progress
Sagduyu, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,023
Enhanced Aggressive Behavior in Mice Lacking 5-HT 1B Receptor
Saudou, F., Amara, D. A., Dierich, A., LeMeur, M., Ramboz, S., Ségu, L., Buhot, M.-C., & Hen, R. (1994) · Science · doi:10.1126/science.8091214 · Cited by 839
Self-citationNeuropsychopharmacology : The Fifth Generation of Progress
Davis, K. L., Charney, D. S., Coyle, J. T., & Nemeroff, C. B. (2002) · Lippincott Williams & Wilkins eBooks · Cited by 747
Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression
Dulawa, S. C., Holick, K. A., Gundersen, B., & Hen, R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300433 · Cited by 671
Self-citationBrain anatomy and sensorimotor gating in Asperger's syndrome
McAlonan, G. M. (2002) · Brain · doi:10.1093/brain/awf150 · Cited by 447
Gordon, C. T. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820180039004 · Cited by 390
Cited by
Sorted by citations
Pittenger, C., Bloch, M. H., & Williams, K. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.006 · Cited by 426
Haenisch, B., & Bönisch, H. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.12.002 · Cited by 215
Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes
Kalueff, A. V., Olivier, J. D. A., Nonkes, L. J. P., & Homberg, J. R. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.08.003 · Cited by 206
Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder
Ahmari, S. E., Risbrough, V. B., Geyer, M. A., & Simpson, H. B. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.308 · Cited by 189
Self-citationAnimal models of depression and anxiety: What do they tell us about human condition?
Neumann, I. D., Wegener, G., Homberg, J. R., Cohen, H., Slattery, D. A., Zohar, J., Olivier, J. D. A., & Mathé, A. A. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.028 · Cited by 164
Ahmari, S. E., & Dougherty, D. D. (2015) · Depression and Anxiety · doi:10.1002/da.22367 · Cited by 128
Genetic Models of Sensorimotor Gating: Relevance to Neuropsychiatric Disorders
Powell, S. B., Weber, M., & Geyer, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_195 · Cited by 127
Self-citationMurphy, D. L., Moya, P. R., Fox, M. A., Rubenstein, L. M., Wendland, J. R., & Timpano, K. R. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0435 · Cited by 112
Placental serotonin: implications for the developmental effects of SSRIs and maternal depression
Velasquez, J. C., Goeden, N., & Bonnin, A. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00047 · Cited by 106
Zike, I. D., Xu, T., Hong, N., & Veenstra-VanderWeele, J. M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.09.012 · Cited by 83
Animal models of obsessive–compulsive disorder: utility and limitations
Alonso, P., López‐Solà, C., Real, E., Segalàs, C., & Menchón, J. M. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s62785 · Cited by 88
Fluoxetine Exerts Age-Dependent Effects on Behavior and Amygdala Neuroplasticity in the Rat
Homberg, J. R., Olivier, J. D. A., Blom, T., Arentsen, T., van Brunschot, C., Schipper, P., Korte-Bouws, G. A. H., van Luijtelaar, G., & Reneman, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016646 · Cited by 89
Marble-burying behavior test as a murine model of compulsive-like behavior
Dixit, P. V., Sahu, R. A., & Mishra, D. K. (2020) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2020.106676 · Cited by 87
Shanahan, N. A., Velez, L. P., Masten, V. L., & Dulawa, S. C. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.032 · Cited by 72
Self-citationAnimal models of obsessive-compulsive spectrum disorders
d'Angelo, L.-S. C., Eagle, D. M., Grant, J. E., Fineberg, N. A., Robbins, T. W., & Chamberlain, S. R. (2013) · CNS Spectrums · doi:10.1017/s1092852913000564 · Cited by 74
Using mice to model Obsessive Compulsive Disorder: From genes to circuits
Ahmari, S. E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.009 · Cited by 71
Pittenger, C., Adams, T. G., Gallezot, J., Crowley, M. J., Nabulsi, N., Ropchan, J., Gao, H., Kichuk, S. A., Simpson, R., Billingslea, E., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.021 · Cited by 55
Wolmarans, D. W., Stein, D. J., & Harvey, B. H. (2016) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-016-0413-8 · Cited by 55
5‐HT1B autoreceptor regulation of serotonin transporter activity in synaptosomes
Hagan, C. E., McDevitt, R. A., Liu, Y. K., Furay, A. R., & Neumaier, J. F. (2012) · Synapse · doi:10.1002/syn.21608 · Cited by 55
Coba, M. P., Ramaker, M. J., Ho, E. V., Thompson, S. L., Komiyama, N. H., Grant, S. G. N., Knowles, J. A., & Dulawa, S. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-20610-y · Cited by 49
Self-citationVelez, L., Sokoloff, G., Miczek, K. A., Palmer, A. A., & Dulawa, S. C. (2009) · Behavior Genetics · doi:10.1007/s10519-009-9325-5 · Cited by 52
Self-citationAssessing the validity of current mouse genetic models of obsessive-compulsive disorder
Wang, L., Simpson, H. B., & Dulawa, S. C. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832a80ad · Cited by 50
Self-citationPharmacotherapeutic Strategies and New Targets in OCD
Pittenger, C. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_204 · Cited by 54
Steiner, J. A., Carneiro, A. M., Wright, J., Matthies, H. J. G., Prasad, H. C., Nicki, C. K., Dostmann, W. R., Buchanan, C. C., Corbin, J. D., Francis, S. H., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-26 · Cited by 48
Arakawa, H. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113432 · Cited by 49
Bidirectional regulation of emotional memory by 5-HT1B receptors involves hippocampal p11
Eriksson, T. M., Alvarsson, A., Stan, T. L., Zhang, X., Hascup, K. N., Hascup, E. R., Kehr, J., Gerhardt, G. A., Warner-Schmidt, J., Arango-Lievano, M., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.130 · Cited by 45
Rogers, J., Li, S., Lanfumey, L., Hannan, A. J., & Renoir, T. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.06.009 · Cited by 47
Jennings, K. A., Lesch, K., Sharp, T., & Cragg, S. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07001.x · Cited by 43
Hyperactivity of indirect pathway-projecting spiny projection neurons promotes compulsive behavior
Piantadosi, S. C., Manning, E. E., Chamberlain, B. L., Hyde, J., LaPalombara, Z., Bannon, N. M., Pierson, J. L., Namboodiri, V. M. K., & Ahmari, S. E. (2024) · Nature Communications · doi:10.1038/s41467-024-48331-z · Cited by 41
Manning, E. E., Wang, A. Y., Saikali, L. M., Winner, A. S., & Ahmari, S. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-88769-5 · Cited by 37
Serotonin Transporter Deficiency Increases Abdominal Fat in Female, but Not Male Rats
Homberg, J. R., la Fleur, S. E., & Cuppen, E. P. J. G. (2009) · Obesity · doi:10.1038/oby.2009.139 · Cited by 36
Samocha, K. E., Lim, J. E., Cheng, R., Sokoloff, G., & Palmer, A. A. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00613.x · Cited by 35
Btbd3 expression regulates compulsive-like and exploratory behaviors in mice
Thompson, S. L., Welch, A. C., Ho, E. V., Bessa, J. M., Portugal‐Nunes, C., Morais, M., Young, J. W., Knowles, J. A., & Dulawa, S. C. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0558-7 · Cited by 35
Self-citationHTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory
Drago, A., Alboni, S., Brunello, N., Ronchi, D. D., & Serretti, A. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0724-6 · Cited by 36
5-HT1B receptor modulation of the serotonin transporter in vivo: Studies using KO mice
Montañez, S., Munn, J. L., Owens, W. A., Horton, R. E., & Daws, L. C. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.11.004 · Cited by 34
Ho, E. V., Thompson, S. L., Katzka, W. R., Sharifi, M. F., Knowles, J. A., & Dulawa, S. C. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4086-8 · Cited by 32
Self-citationCosta, D. L. D. C., Shavitt, R. G., Cesar, R. C., Joaquim, M. A., Borcato, S., Valério, C., Miguel, E. C., & Diniz, J. B. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.07.006 · Cited by 33
Woehrle, N. S., Klenotich, S. J., Jamnia, N., Ho, E. V., & Dulawa, S. C. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2985-0 · Cited by 31
Self-citationSertraline exposure leads to small left heart syndrome in adult mice
Haskell, S. E., Hermann, G. M., Reinking, B. E., Volk, K. A., Peotta, V. A., Zhu, V. L., & Roghair, R. D. (2012) · Pediatric Research · doi:10.1038/pr.2012.183 · Cited by 31
Abnormal repetitive behaviors in zebrafish and their relevance to human brain disorders
Zabegalov, K. N., Khatsko, S. L., Lakstygal, A. M., Demin, K. A., Cleal, M., Fontana, B. D., McBride, S. D., Harvey, B. H., de Abreu, M. S., Parker, M. O., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.03.044 · Cited by 32
Animal Models for OCD Research
Chamberlain, B. L., & Ahmari, S. E. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_196 · Cited by 27
Duncan, M. J., Hester, J., Hopper, J. A., & Franklin, K. M. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07186.x · Cited by 27
Dere, E., Winkler, D., Ritter, C., Ronnenberg, A., Poggi, G., Patzig, J., Gernert, M., Müller, C. P., Nave, K., Ehrenreich, H., et al. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.021 · Cited by 27
Popova, N. K., Naumenko, V. S., Tibeikina, M. A., & Kulikov, A. V. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22155 · Cited by 25
Ketamine induces immediate and delayed alterations of OCD-like behavior
Thompson, S. L., Welch, A. C., Iourinets, J., & Dulawa, S. C. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05397-8 · Cited by 24
Self-citationEmerging drugs to treat obsessive–compulsive disorder
Pallanti, S., Grassi, G., & Cantisani, A. (2013) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.875157 · Cited by 23
Effects of oxytocin on serotonin 1B agonist-induced autism-like behavior in mice
Lawson, S. K., Gray, A. C., & Woehrle, N. S. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.07.027 · Cited by 26
Bond, C. M., Johnson, J. C., Chaudhary, V., McCarthy, E. M., McWhorter, M. L., & Woehrle, N. S. (2019) · Brain Research · doi:10.1016/j.brainres.2019.06.001 · Cited by 27
Gene knockout animal models of depression, anxiety and obsessive compulsive disorders
Scherma, M., Giunti, E., Fratta, W., & Fadda, P. (2019) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000238 · Cited by 21
Chen, X., Yue, J.-H., Luo, Y., Huang, L.-Y., Li, B.-X., & Wen, S.-L. (2021) · Behavioral and Brain Functions · doi:10.1186/s12993-021-00177-x · Cited by 19
Wilson, C., Gattuso, J. J., Hannan, A. J., & Renoir, T. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106223 · Cited by 22
PREPULSE INHIBITION DEFICITS ONLY IN FEMALES WITH OBSESSIVE-COMPULSIVE DISORDER
Steinman, S. A., Ahmari, S. E., Choo, T. H., Kimeldorf, M. B., Feit, R., Loh, S. A., Risbrough, V. B., Geyer, M. A., STEINGLASS, J. E., Wall, M. M., et al. (2016) · Depression and Anxiety · doi:10.1002/da.22474 · Cited by 21
Self-citationCompton, D. M., Dietrich, K. L., Selinger, M. C., & Testa, E. K. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.01.021 · Cited by 21
Andrade, P., Fernández‐Guasti, A., Carrillo-Ruiz, J. D., Ulloa, R. E., Ramírez, Y., Reyes, R., & Jiménez, F. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.026 · Cited by 18
Thompson, S. L., & Dulawa, S. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211239 · Cited by 18
Self-citationAronsen, D., Webster, J., & Schenk, S. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.05.008 · Cited by 17
Uchiumi, O., Kasahara, Y., Fukui, A., Hall, F. S., Uhl, G. R., & Sora, I. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.016 · Cited by 17
Vahabzadeh, A. B. N., & McDougle, C. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.05213-8 · Cited by 18
Banerjee, E., Banerjee, D., Chatterjee, A., Sinha, S., & Nandagopal, K. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.04.003 · Cited by 17
Compton, D. M., Selinger, M. C., Westman, E., & Otero, P. (2011) · Psychology & Neuroscience · doi:10.3922/j.psns.2011.1.018 · Cited by 16
O’Reilly, K. C., Connor, M., Pierson, J. L., Shuffrey, L. C., Blakely, R., Ahmari, S. E., & Veenstra-VanderWeele, J. M. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05758-8 · Cited by 15
Zou, J., Gopalakrishnan, S., Parker, C. C., Nicod, J., Mott, R., Cai, N., Lionikas, A., Davies, R. W., Palmer, A. A., & Flint, J. (2021) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkab394 · Cited by 11
Marques, A. M., Macena, M. V., Cardoso, A. R., Hammes, C. S. O., Pinheiro, F. M. L., Castro, N. G., & Neves, G. A. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05485-0 · Cited by 10
Animal Models of Tourette Syndrome and Obsessive-Compulsive Disorder
Pittenger, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00047-0 · Cited by 10
Ho, E. V., Welch, A. C., Thompson, S. L., Knowles, J. A., & Dulawa, S. C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0277446 · Cited by 9
Self-citationMcDougall, S. A., Robinson, J. A. M., Ramirez, E. L., & Diaz, H. A. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172857 · Cited by 9
Borba, J. V., Canzian, J., Resmim, C. M., da Silva, R. M., Duarte, M. C. F., Mohammed, K. A., Schoenau, W., Adedara, I. A., & Rosemberg, D. B. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105715 · Cited by 9
Manning, E. E., & Ahmari, S. E. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818783896 · Cited by 8
Kishi, T., Moriwaki, M., Kitajima, T., Kawashima, K., Okochi, T., Fukuo, Y., Furukawa, O., Naitoh, H., Fujita, K., & Iwata, N. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1787-x · Cited by 7
Manning, E. E., Wang, A. Y., Saikali, L. M., Winner, A. S., & Ahmari, S. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/694935 · Cited by 8
Payamani, M., Abdollahi-Keyvani, S.-T., Sajjadi, M., Akhondzadeh, S., Javid, R., Nakhaei-Zadeh, R., Jalalian-Javadpour, M., & Vaseghi, S. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174027 · Cited by 7
N-acetylcysteine blocks serotonin 1B agonist-induced OCD-related behavior in mice.
Allen, E. M., Hughes, E. F., Anderson, C. J., & Woehrle, N. S. (2018) · Behavioral Neuroscience · doi:10.1037/bne0000251 · Cited by 7
Anticataleptic effects of 5-HT1B receptors in the globus pallidus
Wang, H., Chen, X., Chen, W., Xue, Y., Wei, L., & Chen, L. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.09.002 · Cited by 6
Vinkers, C. H., Groenink, L., Pattij, T., Olivier, B., & Bouwknecht, J. A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.06.018 · Cited by 6
Circadian rhythmicity in serotonin transporter knockout mice
Pang, R. D., Holschneider, D. P., & Miller, J. D. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.07.018 · Cited by 5
Fitzgerald, P. J. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.856010 · Cited by 5
McDougall, S. A., Roe, M. J., Robinson, J. A. M., Cotter, L. L., Gonzalez, D. J., Gleason, D. C., & Crawford, C. A. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175019 · Cited by 4
Pathophysiological Modeling of Obsessive-Compulsive Disorder: Challenges, and Progress
Pittenger, C. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.005 · Cited by 4
Bidirectional Behavioral Selection in Mice: A Novel Pre-clinical Approach to Examining Compulsivity
Mitra, S., & Bult‐Ito, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.716619 · Cited by 4
Acute serotonin 1B/1A receptor activation impairs behavioral flexibility in C57BL/6J mice
Oliver, B. L., Burdette, M. H., Pahua, A. E., Cavazos, C., Morales, C. A., Alvarez, B. D., & Amodeo, D. A. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113865 · Cited by 3
Roles of serotonin in the fetal brain
Zhao, Q., & Bonnin, A. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00024-4 · Cited by 3
McDougall, S. A., Montejano, N. R., Park, G. I., & Robinson, J. A. M. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-02011-z · Cited by 3
Zou, J., Gopalakrishnan, S., Parker, C. C., Nicod, J., Mott, R., Cai, N., Lionikas, A., Davies, R. W., Palmer, A. A., & Jonathan Flint, C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.05.429998 · Cited by 3
Bai, T., Wang, Y., Ruan, H., Zhang, G., Gao, J., Zheng, Z., Li, D., Zhao, Q., Han, H., Fan, Q., et al. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02375-5 · Cited by 2
Wilson, C., Hannan, A. J., & Renoir, T. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109801 · Cited by 3
Yi, M., Zhang, Y., Wang, Y., Su, N., & Liu, S. (2015) · Asia-Pacific Psychiatry · doi:10.1111/appy.12196 · Cited by 2
Uncovering novel therapeutics for schizophrenia: a multitarget approach using the CANDO platformPreprint
Hu, Y., Elefteriou, K., Falls, Z., & Samudrala, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.24.684257 · Cited by 1
SEROTONIN IN EMOTIONAL MEMORY PROCESSES: NEUROPHARMACOLOGICAL STUDIES WITH EMPHASIS ON DEPRESSION
Eriksson, T. (2012) · Figshare
The Role of the Serotonin Transporter as a Genetic Risk Factor in the Development of Drug Addiction
Brox, B. W. (2016) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17014610.v1
The role of 5-HT1A and 5-HT1B receptors in MDMA self-administration
Aronsen, D. (2016) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17014775
McDougall, S. A., Taylor, J. A., Roe, M. J., & Greenwood, C. J. (2021) · Psychopharmacology · doi:10.1007/s00213-021-06012-5
Ho, E. V., Welch, A. C., Knowles, J., & Dulawa, S. C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.28.514214
Self-citationChen, X., Yue, J., Luo, Y., Huang, L., Li, B., & Wen, S. (2021) · Figshare · doi:10.6084/m9.figshare.14615399
Chen, X., Yue, J., Luo, Y., Huang, L., Li, B., & Wen, S. (2021) · Figshare · doi:10.6084/m9.figshare.14615396
Chen, X., Yue, J., Luo, Y., Huang, L., Li, B., & Wen, S. (2021) · Figshare · doi:10.6084/m9.figshare.14615390
Contribution des récepteurs 5-HT4 à la motivation et la prise de décision de manger
Jean, A. (2010) · theses.fr (ABES) · doi:10.70675/804a4a80z3585z415fzba64z9a7f076dd88d
Metadata
- Authors
- Shanahan, N. A., Holick Pierz, K. A., Masten, V. L., Waeber, C., Ansorge, M., Gingrich, J. A., Geyer, M. A., Hen, R., & Dulawa, S. C.
- Affiliations
- University of California San Diego (US)
- Harvard University (US)
- Columbia University (US)
- University of Chicago (US)
- Corresponding author
- Dulawa, Stephanie C.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 65
- Issue
- 5
- Pages
- 401-408
- ISSN
- 0006-3223 (ISSN-L)
- PMC
- PMC2674010
- OpenAlex
- W2058616430
- Cited by
- 102
- References
- 60
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 13 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 1 · 2016: 8 · 2015: 5 · 2014: 5 · 2013: 9 · 2012: 8
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (K01MH071555, R01MH079424)
- National Institute on Drug Abuse (DA 02925, T32DA07255-15, R01DA002925, T32DA007255)
- National Institute of Neurological Disorders and Stroke (R01NS049263, R21NS052195)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- serotonin transporter, 5-HT1B receptor, obsessive-compulsive disorder, prepulse inhibition, fluoxetine, serotonin reuptake inhibitors, 8-OH-DPAT, 5-HT1A receptor, globus pallidus, substantia nigra, gain-of-function alleles
- MeSH terms
- Animals, Female, Fluoxetine, Globus Pallidus, Indoles, Mice, Inbred BALB C, Motor Activity, Oxadiazoles, Piperazines, Pyridines, Reflex, Startle, Substantia Nigra, 8-Hydroxy-2-(di-n-propylamino)tetralin, Mice, Knockout, Receptor, Serotonin, 5-HT1B, Serotonin Plasma Membrane Transport Proteins, Mice, Serotonin 5-HT1 Receptor Agonists, Serotonin 5-HT1 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review